Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study.

El Jurdi N, Filali-Mouhim A, Salem I, Retuerto M, Dambrosio NM, Baer L, Lazarus HM, Caimi P, Cooper B, Tomlinson B, Metheny L, Malek E, Otegbeye F, Sekaly RP, Ghannoum M, de Lima M.

Biol Blood Marrow Transplant. 2019 Apr 5. pii: S1083-8791(19)30230-7. doi: 10.1016/j.bbmt.2019.04.007. [Epub ahead of print]

PMID:
30959164
2.

Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms.

Hager CL, Isham N, Schrom KP, Chandra J, McCormick T, Miyagi M, Ghannoum MA.

MBio. 2019 Apr 2;10(2). pii: e00338-19. doi: 10.1128/mBio.00338-19.

3.

Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV.

Weiner LD, Retuerto M, Hager CL, El Kamari V, Shan L, Sattar A, Kulkarni M, Funderburg N, Ghannoum MA, Dirajlal-Fargo S, McComsey GA.

AIDS Res Hum Retroviruses. 2019 May;35(5):461-472. doi: 10.1089/AID.2018.0252. Epub 2019 Apr 4.

PMID:
30784316
4.

Diversity of Ocular Surface Bacterial Microbiome Adherent to Worn Contact Lenses and Bacterial Communities Associated With Care Solution Use.

Retuerto MA, Szczotka-Flynn L, Mukherjee PK, Debanne S, Iyengar SK, Richardson B, Cameron M, Ghannoum MA.

Eye Contact Lens. 2019 Feb 1. doi: 10.1097/ICL.0000000000000578. [Epub ahead of print]

PMID:
30724840
5.

A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.

Ghannoum M, Long L, Kunze G, Sarkany M, Osman-Ponchet H.

Mycoses. 2019 Jun;62(6):494-501. doi: 10.1111/myc.12896. Epub 2019 Mar 18.

PMID:
30667544
6.

Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus.

Arikan-Akdagli S, Ghannoum M, Meis JF.

J Fungi (Basel). 2018 Dec 5;4(4). pii: E129. doi: 10.3390/jof4040129. Review.

7.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.

Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan.

8.

Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients.

Chandra J, Retuerto M, Seité S, Martin R, Kus M, Ghannoum MA, Baron E, Mukherjee PK.

J Drugs Dermatol. 2018 Oct 1;17(10):1039-1048.

PMID:
30365583
9.

A Novel Actin Binding Drug with In Vivo Efficacy.

Ravichandran A, Geng M, Hull KG, Li J, Romo D, Lu SE, Albee A, Nutter C, Gordon DM, Ghannoum MA, Lockless SW, Smith L.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01585-18. doi: 10.1128/AAC.01585-18. Print 2019 Jan.

10.

Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens.

Greenberg M, Kuo D, Jankowsky E, Long L, Hager C, Bandi K, Ma D, Manoharan D, Shoham Y, Harte W, Ghannoum MA, Shoham M.

Sci Rep. 2018 Oct 1;8(1):14578. doi: 10.1038/s41598-018-32829-w.

11.

The Gut Microbiome as a Major Regulator of the Gut-Skin Axis.

Salem I, Ramser A, Isham N, Ghannoum MA.

Front Microbiol. 2018 Jul 10;9:1459. doi: 10.3389/fmicb.2018.01459. eCollection 2018. Review.

12.

Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection.

Mukherjee PK, Chandra J, Retuerto M, Tatsuoka C, Ghannoum MA, McComsey GA.

PLoS One. 2018 Jul 11;13(7):e0200285. doi: 10.1371/journal.pone.0200285. eCollection 2018.

13.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

14.

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.

Hager CL, Larkin EL, Long LA, Ghannoum MA.

J Antimicrob Chemother. 2018 Aug 1;73(8):2085-2088. doi: 10.1093/jac/dky153.

15.

Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.

Presti RM, Handley SA, Droit L, Ghannoum M, Jacobson M, Shiboski CH, Webster-Cyriaque J, Brown T, Yin MT, Overton ET.

AIDS. 2018 Jun 19;32(10):1279-1287. doi: 10.1097/QAD.0000000000001811.

PMID:
29851662
16.

Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis.

Clark HL, Minns MS, Sun Y, de Jesus T, Ghannoum MG, Pearlman E.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1589-1598. doi: 10.1167/iovs.17-22585.

17.

The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.

Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK, Pizarro TT, Ghannoum MA, Ilic S, McDonald C, Cominelli F.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1005-1020. doi: 10.1093/ibd/izy060.

18.

Examining the Benefits of the Boron-Based Mechanism of Action and Physicochemical Properties of Tavaborole in the Treatment of Onychomycosis.

Markinson B, Ghannoum M, Winter T, Rycerz A, Rock F, Gupta AK.

J Am Podiatr Med Assoc. 2018 Jan;108(1):12-19. doi: 10.7547/16-154. Review.

PMID:
29547036
19.

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris.

Hager CL, Larkin EL, Long L, Zohra Abidi F, Shaw KJ, Ghannoum MA.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02319-17. doi: 10.1128/AAC.02319-17. Print 2018 Mar.

20.

Biofilms and beyond: expanding echinocandin utility.

Larkin EL, Dharmaiah S, Ghannoum MA.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i73-i81. doi: 10.1093/jac/dkx451. Review.

PMID:
29304214

Supplemental Content

Loading ...
Support Center